The European (and thus, Danish) guidelines on AF patients with ACS undergoing PCI recommends clopidogrel as the P2Y12 inhibitor of choice.12,41 The use of ticagrelor or prasugrel is considered an active choice by the treating physician. This evidence concerns the gene P2RY12 and atrial fibrillation.